S K Papadopoulou1, P Tsintavis, P Potsaki, D Papandreou. 1. Dimitrios Papandreou, PhD, M.Ed, MS, RDN, Professor of Nutrition and Dietetics Department of Health Sciences, CNHS, Abu Dhabi, UAE, Email: Dimitrios.papandreou@zu.ac.ae.
Abstract
BACKGROUND: Sarcopenia is an age-related disease which leads to a decline in muscle mass and function and is one of the most important health issues in elderly people with a high rate and variety of adverse outcomes. OBJECTIVE: The current systematic review and meta-analysis study was carried out to estimate the overall prevalence of sarcopenia in both males and females in different regions around the world and to show the major differences in its occurrence among different populations. DESIGN: A systematic review and meta-analysis of studies published in PubMed (Medline) and Scopus. PARTICIPANTS: Community dwelling, nursing home and hospitalized older adults aged over 60 years. MEASUREMENTS: Sarcopenia was defined by the major validated diagnostic criteria, such as the European Working Group on Sarcopenia in Older People (EWGSOP), the Asian Working Group for Sarcopenia (AWGS) and the International Working Group on Sarcopenia (IWGS). The model used was the random effect model for estimating the prevalence of sarcopenia. The sex-specific prevalence of sarcopenia as well as 95% CI (Confidence interval) were calculated using MetaXL (version 5.3). Heterogeneity assessment was carried out by subgroup analysis. RESULTS: We included 41 studies with a total of 34955 participants. The prevalence of sarcopenia in community-dwelling individuals in the included studies were 11% (95% CI: 8-13%) in men and 9% (95% CI: 7-11%) in women. The prevalence of sarcopenia in nursing-home individuals in the included studies were 51% (95% CI: 37-66%) in men and 31% (95% CI: 22-42%) in women and in hospitalized individuals were 23% (95%, CI: 15-30%) in men and 24% (95% CI: 14-35%) in women. CONCLUSIONS: Despite the differences encountered between the studies, regarding diagnostic tools used to measure of muscle mass, different regions around the world and different populations and clinical settings, this systematic review revealed that a significant proportion of old people has sarcopenia (major in nursing homes), even in populations healthy in general. However, sarcopenia is caused by the aging progress, early diagnosis and individualized care, including physical activity and nutrition, can prevent some adverse outcomes in all populations.
BACKGROUND:Sarcopenia is an age-related disease which leads to a decline in muscle mass and function and is one of the most important health issues in elderly people with a high rate and variety of adverse outcomes. OBJECTIVE: The current systematic review and meta-analysis study was carried out to estimate the overall prevalence of sarcopenia in both males and females in different regions around the world and to show the major differences in its occurrence among different populations. DESIGN: A systematic review and meta-analysis of studies published in PubMed (Medline) and Scopus. PARTICIPANTS: Community dwelling, nursing home and hospitalized older adults aged over 60 years. MEASUREMENTS: Sarcopenia was defined by the major validated diagnostic criteria, such as the European Working Group on Sarcopenia in Older People (EWGSOP), the Asian Working Group for Sarcopenia (AWGS) and the International Working Group on Sarcopenia (IWGS). The model used was the random effect model for estimating the prevalence of sarcopenia. The sex-specific prevalence of sarcopenia as well as 95% CI (Confidence interval) were calculated using MetaXL (version 5.3). Heterogeneity assessment was carried out by subgroup analysis. RESULTS: We included 41 studies with a total of 34955 participants. The prevalence of sarcopenia in community-dwelling individuals in the included studies were 11% (95% CI: 8-13%) in men and 9% (95% CI: 7-11%) in women. The prevalence of sarcopenia in nursing-home individuals in the included studies were 51% (95% CI: 37-66%) in men and 31% (95% CI: 22-42%) in women and in hospitalized individuals were 23% (95%, CI: 15-30%) in men and 24% (95% CI: 14-35%) in women. CONCLUSIONS: Despite the differences encountered between the studies, regarding diagnostic tools used to measure of muscle mass, different regions around the world and different populations and clinical settings, this systematic review revealed that a significant proportion of old people has sarcopenia (major in nursing homes), even in populations healthy in general. However, sarcopenia is caused by the aging progress, early diagnosis and individualized care, including physical activity and nutrition, can prevent some adverse outcomes in all populations.
Entities:
Keywords:
Sarcopenia; elderly; nursing home; reduced muscle mass
Authors: Francesco Landi; Rosa Liperoti; Domenico Fusco; Simona Mastropaolo; Davide Quattrociocchi; Anna Proia; Andrea Russo; Roberto Bernabei; Graziano Onder Journal: J Gerontol A Biol Sci Med Sci Date: 2011-03-10 Impact factor: 6.053
Authors: Roger A Fielding; Bruno Vellas; William J Evans; Shalender Bhasin; John E Morley; Anne B Newman; Gabor Abellan van Kan; Sandrine Andrieu; Juergen Bauer; Denis Breuille; Tommy Cederholm; Julie Chandler; Capucine De Meynard; Lorenzo Donini; Tamara Harris; Aimo Kannt; Florence Keime Guibert; Graziano Onder; Dimitris Papanicolaou; Yves Rolland; Daniel Rooks; Cornel Sieber; Elisabeth Souhami; Sjors Verlaan; Mauro Zamboni Journal: J Am Med Dir Assoc Date: 2011-03-04 Impact factor: 4.669
Authors: Lara Bianchi; Luigi Ferrucci; Antonio Cherubini; Marcello Maggio; Stefania Bandinelli; Elisabetta Savino; Gloria Brombo; Giovanni Zuliani; Jack M Guralnik; Francesco Landi; Stefano Volpato Journal: J Gerontol A Biol Sci Med Sci Date: 2015-09-02 Impact factor: 6.053
Authors: Anna Maria Martone; Lara Bianchi; Pasquale Abete; Giuseppe Bellelli; Mario Bo; Antonio Cherubini; Francesco Corica; Mauro Di Bari; Marcello Maggio; Giovanna Maria Manca; Emanuele Marzetti; Maria Rosaria Rizzo; Andrea Rossi; Stefano Volpato; Francesco Landi Journal: J Cachexia Sarcopenia Muscle Date: 2017-09-14 Impact factor: 12.910
Authors: Richard Matthew Dodds; Antoneta Granic; Karen Davies; Thomas B L Kirkwood; Carol Jagger; Avan Aihie Sayer Journal: J Cachexia Sarcopenia Muscle Date: 2016-11-16 Impact factor: 12.910
Authors: Harnish P Patel; Holly Emma Syddall; Karen Jameson; Sian Robinson; Hayley Denison; Helen C Roberts; Mark Edwards; Elaine Dennison; Cyrus Cooper; Avan Aihie Sayer Journal: Age Ageing Date: 2013-02-05 Impact factor: 10.668
Authors: Stephanie A Studenski; Katherine W Peters; Dawn E Alley; Peggy M Cawthon; Robert R McLean; Tamara B Harris; Luigi Ferrucci; Jack M Guralnik; Maren S Fragala; Anne M Kenny; Douglas P Kiel; Stephen B Kritchevsky; Michelle D Shardell; Thuy-Tien L Dam; Maria T Vassileva Journal: J Gerontol A Biol Sci Med Sci Date: 2014-05 Impact factor: 6.053
Authors: Alfonso J Cruz-Jentoft; Francesco Landi; Stéphane M Schneider; Clemente Zúñiga; Hidenori Arai; Yves Boirie; Liang-Kung Chen; Roger A Fielding; Finbarr C Martin; Jean-Pierre Michel; Cornel Sieber; Jeffrey R Stout; Stephanie A Studenski; Bruno Vellas; Jean Woo; Mauro Zamboni; Tommy Cederholm Journal: Age Ageing Date: 2014-09-21 Impact factor: 10.668
Authors: Nada Almohaisen; Matthew Gittins; Chris Todd; Jana Sremanakova; Anne Marie Sowerbutts; Amal Aldossari; Asrar Almutairi; Debra Jones; Sorrel Burden Journal: Nutrients Date: 2022-04-07 Impact factor: 6.706